EA200100662A1 - Способ и композиция для поддержания и восстановления целостности кишки - Google Patents

Способ и композиция для поддержания и восстановления целостности кишки

Info

Publication number
EA200100662A1
EA200100662A1 EA200100662A EA200100662A EA200100662A1 EA 200100662 A1 EA200100662 A1 EA 200100662A1 EA 200100662 A EA200100662 A EA 200100662A EA 200100662 A EA200100662 A EA 200100662A EA 200100662 A1 EA200100662 A1 EA 200100662A1
Authority
EA
Eurasian Patent Office
Prior art keywords
composition
integrity
intestinity
restoring
maintaining
Prior art date
Application number
EA200100662A
Other languages
English (en)
Inventor
Сьюзн Мари Коп
Майкл Скотт Кэплан
Original Assignee
Американ Хоум Продактс Корпорейшн
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Американ Хоум Продактс Корпорейшн filed Critical Американ Хоум Продактс Корпорейшн
Publication of EA200100662A1 publication Critical patent/EA200100662A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C11/00—Milk substitutes, e.g. coffee whitener compositions
    • A23C11/02—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins
    • A23C11/04—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing non-milk fats but no non-milk proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Pediatric Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Описывается способ и готовая форма композиции для использования в данном способе для поддержания и улучшения восстановления целостности кишки у пациентов, нуждающихся в этом, причем способ включает введение пациенту композиции, включающей эффективное количество, по крайней мере, одной n-6 полинасыщенной жирной кислоты в сочетании, по крайней мере, с одной n-3 полинасыщенной жирной кислотой.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200100662A 1998-12-15 1999-12-13 Способ и композиция для поддержания и восстановления целостности кишки EA200100662A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11237498P 1998-12-15 1998-12-15
PCT/US1999/029478 WO2000035443A1 (en) 1998-12-15 1999-12-13 Method and composition for the maintenance and restitution of gut integrity

Publications (1)

Publication Number Publication Date
EA200100662A1 true EA200100662A1 (ru) 2001-12-24

Family

ID=22343574

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200100662A EA200100662A1 (ru) 1998-12-15 1999-12-13 Способ и композиция для поддержания и восстановления целостности кишки

Country Status (14)

Country Link
EP (1) EP1140063A1 (ru)
JP (1) JP2002532420A (ru)
KR (1) KR20020002361A (ru)
CN (1) CN1330542A (ru)
AR (1) AR021669A1 (ru)
AU (1) AU3119600A (ru)
BR (1) BR9916156A (ru)
CA (1) CA2351469A1 (ru)
EA (1) EA200100662A1 (ru)
HU (1) HUP0104760A2 (ru)
IL (1) IL143322A0 (ru)
NO (1) NO20012947L (ru)
PL (1) PL348810A1 (ru)
WO (1) WO2000035443A1 (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2416287T3 (es) 2003-06-23 2013-07-31 Nestec S.A. Empleo de una fórmula nutritiva para la función óptima de la barrera intestinal
US7862808B2 (en) 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
US7303745B2 (en) 2005-04-15 2007-12-04 Bristol-Myers Squibb Company Method for preventing or treating the development of respiratory allergies
US20060233762A1 (en) * 2005-04-15 2006-10-19 Mcmahon Robert J Method for treating or preventing systemic inflammation in formula-fed infants
JP2007063219A (ja) * 2005-09-01 2007-03-15 Juntendo 新生児壊死性腸炎疾患予防剤
SG191784A1 (en) * 2010-12-29 2013-08-30 Abbott Lab Nutritional products including a novel fat system including monoglycerides
MX2017003660A (es) * 2014-09-30 2017-06-26 Nestec Sa Composicion nutricional que se usa para promover la maduracion y/o reparacion del intestino y/o del higado.
WO2023245470A1 (zh) * 2022-06-22 2023-12-28 南方医科大学珠江医院 Mdp类似物在制备用于治疗炎症性肠病的药物中的用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4670285A (en) * 1982-08-06 1987-06-02 The University Of Toronto Innovations Foundation Infant formula
DE3603000A1 (de) * 1986-01-31 1987-08-06 Milupa Ag Neue polyensaeure-reiche fettmischung und deren verwendung bei der herstellung von saeuglingsnahrungen
GB9224809D0 (en) * 1992-11-26 1993-01-13 Scotia Holdings Plc Schizophrenia
US5444054A (en) * 1994-04-01 1995-08-22 Abbott Labatories Method of treating ulcerative colitis
DE4417851C1 (de) * 1994-05-20 1995-10-05 Horst Heirler Diätetisches Lebensmittel mit mittelkettigen Fettsäuren und dessen Verwendung
EP0711503A3 (en) * 1994-11-14 1997-11-26 Scotia Holdings Plc Milk fortified with GLA and/or DGLA
US5993221A (en) * 1997-05-01 1999-11-30 Beth Israel Deaconess Medical Center, Inc. Dietary formulation comprising arachidonic acid and methods of use

Also Published As

Publication number Publication date
AU3119600A (en) 2000-07-03
WO2000035443A1 (en) 2000-06-22
NO20012947D0 (no) 2001-06-14
JP2002532420A (ja) 2002-10-02
AR021669A1 (es) 2002-07-31
EP1140063A1 (en) 2001-10-10
BR9916156A (pt) 2001-09-04
NO20012947L (no) 2001-06-14
PL348810A1 (en) 2002-06-17
IL143322A0 (en) 2002-04-21
CA2351469A1 (en) 2000-06-22
WO2000035443A9 (en) 2000-12-07
HUP0104760A2 (hu) 2002-04-29
KR20020002361A (ko) 2002-01-09
CN1330542A (zh) 2002-01-09

Similar Documents

Publication Publication Date Title
DK0731699T3 (da) Fremgangsmåde til reduktion af legemsfedt i dyr ved indgivelse af konjugeret linolsyre
PT774962E (pt) Utilizacao de dha como uma composicao farmaceutica
ATE227520T1 (de) Ernährungszusammensetzung
WO1999064059A3 (en) Use of secretin for the treatment of autism and other neurological, behavioral and immunological disorders
DE69815155D1 (de) Virtuelle orthodontische zahnbehandlung
DK0880350T3 (da) Behandling af dissemineret sklerose
EE9900428A (et) Köhavastased ravimkoostised
IT1187687B (it) Composizioni farmaceutiche contenenti come principi attivi flavanolignani e fosfolipidi
ATE258792T1 (de) Diät mit hohem lipidgehalt
BR9916860A (pt) Método de reduzir colesterol do sangue e/outriglicerìdios do sangue em um indivìduo mamìfero,preparação em forma de unidade de dosagem, e,conjunto para administrar oralmente a mesma
DK0998287T3 (da) Anvendelse af levobupivacain
EA200100662A1 (ru) Способ и композиция для поддержания и восстановления целостности кишки
AU7438287A (en) Omega-3 fatty acid aided reduction of cyclosporin mephrotoxicity
EA199800717A1 (ru) Способ лечения заболеваний млекопитающих и цвиттерионная композиция
DE69534632D1 (de) Clorimazole metabolite in den behandlung vom sichelzellanämie
EA199800866A1 (ru) Способ снятия боли
PT980253E (pt) Somatostatina e agonistas de somatostatina para tratar a insensibilidade a insulina e a sindrome x
DE69734349D1 (de) Behandlung von knochenleiden mit adrenomedullin
ATE306269T1 (de) Behandlung der exzessiven aggressivität mit olanzapine
IL110888A (en) Pharmaceutical compositions for the treatment of liver diseases comprising a vasodilating compound
ATE164766T1 (de) Zusammensetzung aus asphodelus zur erhöhung der anzahl weisser blutzellen
ATE345138T1 (de) Verfahren und zusammensetzungen zur vorbeugung und behandlung von sodbrennen
RU98102466A (ru) Способ лечения больных остеоартрозом
UA26886C2 (ru) Соли 1,3-диарил-4,5-полиметиленимидазолия, проявляющие анальгезирующую активность
ITAN930037A0 (it) Procedimento per la preparazione di un infuso di radici di zenzero in grado di eliminare la sensibilizzazione di denti e gengive ed infuso ottenuto secondo tale procedimento